| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Full Paper |
1 Medical Physics Unit and 3 Radiology Department "Konstantopoulio - Agia Olga" Hospital, 35 Agias Olgas, Nea Ionia, 142 33, Athens and 2 Medical Physics Department, Medical School, University of Athens, 75 Mikras Asias, 115 27, Athens, Greece
Correspondence: Dr E Yakoumakis, Department of Medical Physics, Medical School, University of Athens, 75 Mikras Asias, 115 27, Athens, Greece
| Abstract |
|---|
|
|
|---|
| Introduction |
|---|
|
|
|---|
It is well known that the sensitometric characteristics of a mammographic film are primarily determined by the film design. Manufacturers often introduce new films with special properties or revise older films in order to improve their clinical performance [24]. While it is the manufacturer's intention that a given film type will always have a predetermined sensitometric behaviour, differences from batch to batch have been reported [5].
However, film design is not the only parameter that determines its performance, since it is also known that the processing conditions can affect the film characteristics. The developing time, the developing chemicals and their temperature are some of the factors that have been reported to affect the sensitometric characteristics of the mammographic films [4, 6]. The processor design is also important, as depending on the developer tank capacity and the design of the film transporting system, the time that the film is immersed into the developer solution may vary among processors with the same nominal developing time.
Many different processing chemicals as well as processors are commercially available. Most new processors have an option of varying not only the developer temperature but also the processing cycle, thus changing the developing time. Chemical and processor manufacturers offer products dedicated for mammography. However, it is not uncommon for radiology departments to use the same processor for both radiological and mammographic film processing. Thus, a given type of mammographic film at different mammographic facilities will be processed under quite different processing conditions that may significantly alter the sensitometric characteristics provided by the manufacturers in the data product sheets.
In this study seven mammographic films were processed under different processing conditions and the effect of the different processors, developing times and chemicals used on the sensitometric characteristics of each film type was investigated.
| Materials and methods |
|---|
|
|
|---|
A sensitometer (X-Rite 334; X-Rite, Grandville, MI) operated in the green spectrum was used to produce a 21-step sensitometric strip. One sensitometric strip from each film type was processed, immediately after exposure, under seven different processing conditions assigned with the codes A, B, C1, C2, D1, D2 and D3 as described in Table 1
.
|
The optical densities (ODs) of the processed sensitometric strips were measured with a calibrated optical densitometer (RMI 331; X-Rite, Grandville, MI). For each sensitometric strip the Hurter and Driffield (H&D) curve was plotted and the following sensitometric parameters were derived: OD of base plus fog (ODb+f), maximum OD (ODmax), average gradient (AG) and film speed. The AG is the slope of H&D curve for ODs from 0.25+ODb+f to 2.0+ODb+f, whereas the film speed was defined as the reciprocal of the relative light exposure required to obtain an OD equal to 1+ODb+f. Using this definition for film speed the higher the film speed value the less exposure is needed to obtain an OD of 1+ODb+f.
It should be noted that while light sensitometry is typically used for film processing quality control, it is also useful for the evaluation of the film performance [7]. The AG is used as an index of the film contrast and the film speed as an index of the dose to the breast. Thus, changes in the sensitometric parameters of a film may reflect corresponding changes in the image quality of the mammograms and in the dose to the breast. However, it should be stressed that in clinical practice, the image quality of a mammogram and the dose to the breast is also dependent on the screen with which the film is combined [2].
| Results |
|---|
|
|
|---|
|
|
|
With the exception of ODb+f where the maximum variation did not exceed 0.03 OD, all the other sensitometric parameters were strongly affected by the processing conditions employed. The ODb+f measured ranged from 0.16 to 0.22 OD and except for HT (0.22 with C1 and 0.21 with C2) all the rest were
0.2 OD. Referring to the ODmax variations (Figure 2a
), one can notice the abrupt increase of ODmax for HDR with D1 and D2. Furthermore, it is also striking that HT, CM-H and AD-M did not exhibit the intense decrease in ODmax with D3 observed in the rest of the films when compared with the ODmax with D1 and D2.
In Figure 2b
it can be seen that depending on the film type, the maximum AG was obtained with the processing conditions D1 (MR5-II, HT, MinR-M, AD-M), B (MinR-2000, CM-H) or D2 (HDR). Finally, from Figure 2c
it can be appreciated that depending on film type the larger speed was obtained for MR5-II with C1, for HT with C1 and D2, for HDR with D1, for MinR-M with C1 and C2, for MinR-2000 with D1 and B and for AD-M and CM-H with D1. The smallest speed was obtained for most of the films with D3, except for MinR-2000 and CM-H where the speed with A was slightly smaller.
Commenting further on Figures 2b and 2c
, it is important to stress that the results of film comparisons in terms of AG or speed are subject to processing conditions. For example, CM-H had larger AG than AD-M with B but with D1 the opposite was true while with D2 both films had almost the same AG. Similarly, MinR-M was much faster than HDR and CM-H with C1 or C2 but with D1 the situation was reversed. Furthermore, it should be noted that there was no specific pattern connecting the variation of AG and speed with the changes of processing conditions. In some cases an increase of AG was accompanied by a decrease in speed but in other cases an increase of both AG and speed was observed.
As far as the AG is concerned (Figure 2c
), two points deserve further attention. First, D1 and D2 are the only processing conditions from those studied, where the AG obtained for MR5-II (an Agfa film that has been replaced in the market by HT and HDR), is satisfactory compared with the typical values of 3.04.0 quoted for the AG of modern films [1]. Second, the preparation of 5 l developer solution with the chemicals designated for preparation of 2.5 l solution (D3), did not degrade the AG as much as expected under this rather unusual case of developing conditions. In fact, with the exception of MR5-II, for the rest of the films the decrease in AG with D3 compared with D2 was insignificant (HT, MinR-M, MinR-2000) or small (HDR, AD-M, CM-H) and still the AG was larger than the AG obtained with those films with other processing conditions (e.g. the AG for CM-H was larger with D3 than with A). However, as can be seen in Figure 2c
, even for this special processor, the reduced developer concentration did generally reduce the film speed but also the ODb+f.
Commenting on Figure 3
, it can be seen that the H&D curves of the different films tested present considerable differences even under the same processing conditions. The specially designed H&D of the HDR should also be noted, where the short shoulder plateau is followed by a quasi-linear part at high ODs and the absence of the typical shoulder plateau for the MR5-II. From these curves, the higher speed of MinR-2000 (also observed with all the processing conditions tested) and the lower speed of AD-M (observed with all except D1 processing conditions as it can be seen Figure 2c
) is clearly indicated.
| Discussion |
|---|
|
|
|---|
This in turn implies that in a mammographic facility where a change of film type, processor, processing cycle or chemistry occurs, the AEC system should be thoroughly checked [1] to determine if a full re-adjustment of the AEC is required or a change in the baseline OD selection would be sufficient. Since such changes may not be brought to the attention of the medical physicist, the importance of the routine sensitometric control is evident. Besides, even without any change in the equipment used, changes in the H&D curve shape may occur for a number of reasons (from processor malfunctions to revisions of film or chemical properties) that can not be perceived without sensitometry.
In this study, it was observed that the sensitometric characteristics of some films are relatively insensitive to the processing conditions while for others the opposite is true. The stability of the sensitometric characteristics of a mammographic film is generally considered to be an advantage, as the behaviour of the film is predictable and manufacturers have often designed or even revised their film design to make it less dependent on processing conditions [2, 3]. On the other hand, the possibility of adjusting the characteristics of a film (mainly the contrast and speed) by deliberately altering the processing conditions is an interesting prospect, since it could be utilized in order to meet certain quality criteria or even accommodate the different preferences that may exist among radiologists. It should be mentioned, however, that in clinical practice a change of tube voltage setting, target/filter combination or cassette could be employed for the same purpose.
New films are in general of high contrast and as it was seen, with the exception of MR5-II, for the rest of the films an AG from 2.95 to 4.36 was obtained for the various processing conditions used. In the European quality control protocol [1], the implications of using high contrast films are briefly mentioned and a detailed analysis is given by Meeson et al [8]. They concluded that high contrast films (like the AD-M and MinR-2000 included in their work), generally improve the image quality of mammograms especially for fatty breasts. However, in certain occasions, dense breasts were better visualized with films of lower contrast, as dense glandular tissues were underexposed with high contrast films. Now, taking the example of the AD-M film, it was seen that the AG of 4.28 and 4.2 at D1 and D2, respectively, was reduced to 3.75 at D3 and at 3.42 at A, but at the cost of film speed. This decrease in contrast may be useful for moderating the problems reported by Meeson et al [8], while the increase in dose of about 1015% required may improve the image quality as a result of the reduced quantum mottle and the increase of signal to noise ratio [4, 6, 9]. Besides, the decrease in contrast may also be accompanied by an increase in speed, as for MinR-M, where the AG decreases from 3.77 with D1 to 3.40 with C1, with a simultaneous increase of about 30% in speed.
Apart from the implications that high contrast films may have in clinical practice, a reduction in the AG may be required for some technical reasons. In some mammographic units the proper adjustment of the AEC system may be impossible with very high contrast films and for this reason a limit is sometimes given in the technical manuals for the maximum AG that the AEC system can accommodate.
It should be noted that the relatively small effect of the larger developer dilution in AG observed when comparing D3 with D2 cannot be generalized to processors with a single developer tank and shorter developing times. However, when processors like Mamoray MR are used in conjunction with very high contrast films, using a larger dilution in one or both of the developer tanks could be a method for reducing the AG or the ODb+f, if needed.
Finally, an important remark should be made concerning the comparative evaluation of films in terms of image quality and dose to the breast. A film exhibiting a larger AG or film speed than another under certain processing conditions may exhibit lower AG or speed when processing conditions are altered. Thus, the results of comparisons of films or filmscreen combinations should not be generalized to other processing conditions, as they may be misleading.
| Acknowledgments |
|---|
Received for publication October 3, 2003. Revision received January 5, 2004. Accepted for publication March 30, 2004.
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
A D Dimakopoulou, I A Tsalafoutas, E K Georgiou, and E N Yakoumakis Image quality and breast dose of 24 screen-film combinations for mammography Br. J. Radiol., February 1, 2006; 79(938): 123 - 129. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| BJR | DMFR | IMAGING | ALL BIR JOURNALS |